InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the full record of transactions filed by Trojanowski Justin. Director active across 1 company, notably Tempest Therapeutics, Inc.. Aggregated, 1 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €15k. Activity tracked since 28 June 2024. The latest transaction was filed on 28 June 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration